Detalhe da pesquisa
1.
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.
Cell
; 157(2): 369-381, 2014 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24703711
2.
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Blood
; 140(12): 1345-1377, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797463
3.
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
Blood
; 139(15): 2347-2354, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108372
4.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
5.
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia.
Br J Haematol
; 200(2): 170-174, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263593
6.
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Blood
; 137(13): 1792-1803, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024987
7.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
8.
A 17-gene stemness score for rapid determination of risk in acute leukaemia.
Nature
; 540(7633): 433-437, 2016 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27926740
9.
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
N Engl J Med
; 378(13): 1189-1199, 2018 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601269
10.
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients.
Blood
; 133(13): 1457-1464, 2019 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630862
11.
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
Blood
; 133(15): 1630-1643, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803991
12.
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
; 133(10): 1140-1151, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610028
13.
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia.
Blood
; 134(12): 951-959, 2019 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292112
14.
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort.
Ann Hematol
; 100(5): 1169-1179, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704530
15.
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia.
Blood
; 131(24): 2661-2669, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724899
16.
MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML.
Blood
; 132(14): 1526-1534, 2018 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049810
17.
Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.
Blood
; 141(21): 2657-2661, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898087
18.
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.
Eur J Haematol
; 104(3): 162-169, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31724208
19.
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Blood
; 129(4): 424-447, 2017 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27895058
20.
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
Blood
; 129(12): 1636-1645, 2017 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049642